PLX Protalix BioTherapeutics, Inc.: institutional ownership and insider trading
104 funds reported holding $36.1M of Protalix BioTherapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $5.61M, with 17 new positions and 16 funds selling out; over the last 12 months insiders bought $101K and sold $314 on the open market.
Famous investors holding PLX
- Renaissance Technologies (Renaissance Technologies): $2.55M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $884K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $400K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $99.1K, 0.0% of the portfolio
Largest institutional holders of PLX
- BlackRock, Inc. (BLK) — $9.43M
- RENAISSANCE TECHNOLOGIES LLC — $2.55M
- STATE STREET CORP (STT, STT-PG) — $2.29M
- GEODE CAPITAL MANAGEMENT, LLC — $2.28M
- NORTHERN TRUST CORP (NTRS, NTRSO) — $2.15M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.19M
- Stratos Wealth Partners, LTD. — $1.17M
- DIMENSIONAL FUND ADVISORS LP — $1.15M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $1.11M
- MARSHALL WACE, LLP — $1.05M
Recent PLX insider trades
- Dec 19, 2025: Bashan Dror bought 56,000 shares ($101K)
- Nov 18, 2025: Bar-Shalev Amos sold 168 shares ($314)
- Jun 10, 2025: Schwartz Aharon bought 129,000 shares ($206K)
5%+ owners
- HOLD Alapkezelo Zrt.: 5.2% (Schedule 13G, filed Oct 15, 2026)
- BlackRock, Inc.: 5.0% (Schedule 13G, filed Jul 29, 2026)